Free Trial

CareMax (CMAX) Competitors

CareMax logo
$0.42 -0.15 (-26.22%)
(As of 11/27/2024)

CMAX vs. MGRX, ATPC, VSEE, BGLC, ATIP, BACK, ACON, NIVF, GBNHF, and UPHL

Should you be buying CareMax stock or one of its competitors? The main competitors of CareMax include Mangoceuticals (MGRX), Agape ATP (ATPC), Vsee Health (VSEE), BioNexus Gene Lab (BGLC), ATI Physical Therapy (ATIP), IMAC (BACK), Aclarion (ACON), NewGenIvf Group (NIVF), Greenbrook TMS (GBNHF), and UpHealth (UPHL). These companies are all part of the "healthcare" industry.

CareMax vs.

CareMax (NASDAQ:CMAX) and Mangoceuticals (NASDAQ:MGRX) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Mangoceuticals has lower revenue, but higher earnings than CareMax. Mangoceuticals is trading at a lower price-to-earnings ratio than CareMax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareMax$751.10M0.00-$683.35M-$208.440.00
Mangoceuticals$755K8.17-$9.21M-$5.79-0.43

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareMax
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Mangoceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Mangoceuticals had 2 more articles in the media than CareMax. MarketBeat recorded 2 mentions for Mangoceuticals and 0 mentions for CareMax. Mangoceuticals' average media sentiment score of 0.74 beat CareMax's score of 0.00 indicating that Mangoceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
CareMax Neutral
Mangoceuticals Positive

CareMax has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.09, suggesting that its stock price is 109% more volatile than the S&P 500.

65.9% of CareMax shares are held by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are held by institutional investors. 26.9% of CareMax shares are held by company insiders. Comparatively, 39.3% of Mangoceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

CareMax received 9 more outperform votes than Mangoceuticals when rated by MarketBeat users.

CompanyUnderperformOutperform
CareMaxOutperform Votes
9
30.00%
Underperform Votes
21
70.00%
MangoceuticalsN/AN/A

CareMax has a net margin of -99.78% compared to Mangoceuticals' net margin of -1,237.00%. Mangoceuticals' return on equity of -138.00% beat CareMax's return on equity.

Company Net Margins Return on Equity Return on Assets
CareMax-99.78% -175.40% -29.26%
Mangoceuticals -1,237.00%-138.00%-118.88%

Summary

Mangoceuticals beats CareMax on 8 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CMAX vs. The Competition

MetricCareMaxNursing & personal care facilities IndustryBusiness SectorNASDAQ Exchange
Market Cap$1.61M$465.62M$7.22B$9.07B
Dividend YieldN/AN/A2.33%4.23%
P/E Ratio0.0016.3828.2917.17
Price / Sales0.000.21406.37116.95
Price / CashN/A6.4431.0337.86
Price / Book0.031.415.854.78
Net Income-$683.35M-$225.94M$126.23M$225.60M
7 Day PerformanceN/A65.33%4.03%-1.23%
1 Month Performance-36.80%5.71%8.84%3.36%
1 Year Performance-96.73%-38.63%19.33%16.60%

CareMax Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CMAX
CareMax
0.8649 of 5 stars
$0.42
-26.2%
N/A-96.7%$1.61M$751.10M0.001,450Gap Down
MGRX
Mangoceuticals
1.1789 of 5 stars
$2.52
-3.4%
N/A-96.1%$6.27M$755,000.00-0.453News Coverage
Positive News
Gap Down
ATPC
Agape ATP
N/A$1.24
-13.3%
N/A-89.2%$4.95M$1.35M-1.9640Positive News
Gap Down
VSEE
Vsee Health
N/A$1.36
-8.7%
N/AN/A$4.90M$6.38M0.00N/ANews Coverage
BGLC
BioNexus Gene Lab
N/A$0.26
-0.6%
N/A-59.5%$4.65M$9.26M0.0030Positive News
Gap Up
ATIP
ATI Physical Therapy
0.0621 of 5 stars
$0.63
-2.6%
N/A-61.3%$2.79M$741.86M-0.045,600Gap Up
BACK
IMAC
N/A$1.18
-3.2%
N/A-25.3%$1.36M$16.19M0.00180Earnings Report
News Coverage
ACON
Aclarion
1.8597 of 5 stars
$0.10
-1.5%
$1.30
+1,157.3%
-97.0%$1.08M$49,289.000.007Gap Down
NIVF
NewGenIvf Group
0.5038 of 5 stars
$0.29
-10.2%
N/AN/A$1.06M$5.14M0.00N/AGap Down
GBNHF
Greenbrook TMS
N/A$0.01
-6.6%
N/AN/A$465,000.00$73.79M-0.01430Gap Down
UPHL
UpHealth
N/A$0.00
flat
N/A-99.8%$6,000.00$130M0.001,750Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:CMAX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners